Adenosine Dialdehyde (ADOX)
CAS No. 34240-05-6
Adenosine Dialdehyde (ADOX) ( Adenox; Adenosine, periodate oxidized; Periodate-oxidized adenosine; Adenosinedialdehyde )
Catalog No. M27526 CAS No. 34240-05-6
Adenosine dialdehyde is a purine nucleoside analogue. Adenosine dialdehyde is a potent inhibitor of S-Adenosylhomocysteine hydrolase (SAHH) (Ki=3.3 nM). Adenosine Dialdehyde exhibits potent anti-tumor activity in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | Get Quote |
|
10MG | 58 | Get Quote |
|
25MG | 86 | Get Quote |
|
50MG | 149 | Get Quote |
|
100MG | 224 | Get Quote |
|
200MG | 336 | Get Quote |
|
500MG | 565 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdenosine Dialdehyde (ADOX)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdenosine dialdehyde is a purine nucleoside analogue. Adenosine dialdehyde is a potent inhibitor of S-Adenosylhomocysteine hydrolase (SAHH) (Ki=3.3 nM). Adenosine Dialdehyde exhibits potent anti-tumor activity in vivo.
-
DescriptionAdenosine dialdehyde is a purine nucleoside analogue. Adenosine dialdehyde is a potent inhibitor of S-Adenosylhomocysteine hydrolase (SAHH) (Ki=3.3 nM). Adenosine Dialdehyde exhibits potent anti-tumor activity in vivo.(In Vitro):Adenosine dialdehyde suppresses MNB cell replication in tissue culture (1.5 μM, 50% inhibition) .(In Vivo):Adenosine dialdehyde (subcutaneous injection; 1.5-2.5 mg/kg; two 7-day periods interspersed by a 7-day drug free interval( minipump infusion))increases mean life span 80% in diluent treated controls (controls, 21.3 days; AD treated 38.4 days) in mice. Adenosine dialdehyde (subcutaneous injection; 1.5-2.5 mg/kg; infused over a 7-day period ( minipump infusion)) significantly increases the mean life span of tumor bearing mice from 20.9 days in diluent treated controls to 35.3 days in AD treated animals. Adenosine dialdehyde (subcutaneous injection; 2-3 mg/kg; infused over a 7-day period ( minipump infusion)) does not exhibit any hematopoietic toxicity in mice, and it can significantly suppress murine neuroblastoma tumor growth with little systemic toxicity.
-
SynonymsAdenox; Adenosine, periodate oxidized; Periodate-oxidized adenosine; Adenosinedialdehyde
-
PathwayOthers
-
TargetOther Targets
-
RecptorTrypsin-like proteasomes;IFN-γ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34240-05-6
-
Formula Weight265.2
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNc1ncnc2n(cnc12)C(OC(CO)C=O)C=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shadrin N, et al. Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer. Exp Cell Res. 2015 Jan 15;330(2):233-9.
molnova catalog
related products
-
Colivelin TFA (86702...
Colivelin (TFA) is a hybrid peptide composed of ADNF and AGA-(C8R)HNG17, a potent Humanin (HN) derivative.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
Pseudoprotogracillin
Pseudoprotogracillin is a steroidal saponin extracted from Dioscoreae.